Neovaginal Surgery Market Size, Share, Trends, Growth, Production, Consumption, Revenue, Company Analysis and Forecast 2021-2030

Chapter 1.  Introduction

1.1.  Research Objective

1.2.  Scope of the Study

1.3.  Definition

Chapter 2.  Research Methodology

2.1.  Research Approach

2.2.  Data Sources

2.3.  Assumptions & Limitations

Chapter 3.  Executive Summary

3.1.  Market Snapshot

Chapter 4.  Market Variables and Scope

4.1.  Introduction

4.2.  Market Classification and Scope

4.3.  Industry Value Chain Analysis

4.3.1.    Raw Material Procurement Analysis

4.3.2.    Sales and Distribution Channel Analysis

4.3.3.    Downstream Buyer Analysis

Chapter 5.  Market Dynamics Analysis and Trends

5.1.  Market Dynamics

5.1.1.    Market Drivers

5.1.2.    Market Restraints

5.1.3.    Market Opportunities

5.2.  Porter’s Five Forces Analysis

5.2.1.    Bargaining power of suppliers

5.2.2.    Bargaining power of buyers

5.2.3.    Threat of substitute

5.2.4.    Threat of new entrants

5.2.5.    Degree of competition

Chapter 6.  Competitive Landscape

6.1.1.    Company Market Share/Positioning Analysis

6.1.2.    Key Strategies Adopted by Players

6.1.3.    Vendor Landscape

6.1.3.1.        List of Suppliers

6.1.3.2.        List of Buyers

Chapter 7.  Global Neovaginal Surgery Market, By Treatment Type

7.1.  Neovaginal Surgery Market, By Treatment Type, 2020-2030

7.1.1.    Vaginal Agenesis Treatment

7.1.1.1.        Market Revenue and Forecast (2016-2030)

7.1.2.    Vaginal Atresia Treatment

7.1.2.1.        Market Revenue and Forecast (2016-2030)

7.1.3.    Sex Reassignment Surgery

7.1.3.1.        Market Revenue and Forecast (2016-2030)

Chapter 8.  Global Neovaginal Surgery Market, By Product Type

8.1.  Neovaginal Surgery Market, By Product Type, 2020-2030

8.1.1.    Vaginal Dilators

8.1.1.1.        Market Revenue and Forecast (2016-2030)

8.1.2.    Vaginal Stents

8.1.2.1.        Market Revenue and Forecast (2016-2030)

8.1.3.    Laparoscopic Neovaginal Surgeries Kits

8.1.3.1.        Market Revenue and Forecast (2016-2030)

Chapter 9.  Global Neovaginal Surgery Market, Regional Estimates and Trend Forecast

9.1.  North America

9.1.1.    Market Revenue and Forecast, By Treatment Type (2016-2030)

9.1.2.    Market Revenue and Forecast, By Product Type (2016-2030)

9.1.3.    U.S.

9.1.3.1.        Market Revenue and Forecast, By Treatment Type (2016-2030)

9.1.3.2.        Market Revenue and Forecast, By Product Type (2016-2030)

9.1.4.    Rest of North America

9.1.4.1.        Market Revenue and Forecast, By Treatment Type (2016-2030)

9.1.4.2.        Market Revenue and Forecast, By Product Type (2016-2030)

9.2.  Europe

9.2.1.    Market Revenue and Forecast, By Treatment Type (2016-2030)

9.2.2.    Market Revenue and Forecast, By Product Type (2016-2030)

9.2.3.    UK

9.2.3.1.        Market Revenue and Forecast, By Treatment Type (2016-2030)

9.2.3.2.        Market Revenue and Forecast, By Product Type (2016-2030)

9.2.4.    Germany

9.2.4.1.        Market Revenue and Forecast, By Treatment Type (2016-2030)

9.2.4.2.        Market Revenue and Forecast, By Product Type (2016-2030)

9.2.5.    France

9.2.5.1.        Market Revenue and Forecast, By Treatment Type (2016-2030)

9.2.5.2.        Market Revenue and Forecast, By Product Type (2016-2030)

9.2.6.    Rest of Europe

9.2.6.1.        Market Revenue and Forecast, By Treatment Type (2016-2030)

9.2.6.2.        Market Revenue and Forecast, By Product Type (2016-2030)

9.3.  APAC

9.3.1.    Market Revenue and Forecast, By Treatment Type (2016-2030)

9.3.2.    Market Revenue and Forecast, By Product Type (2016-2030)

9.3.3.    India

9.3.3.1.        Market Revenue and Forecast, By Treatment Type (2016-2030)

9.3.3.2.        Market Revenue and Forecast, By Product Type (2016-2030)

9.3.4.    China

9.3.4.1.        Market Revenue and Forecast, By Treatment Type (2016-2030)

9.3.4.2.        Market Revenue and Forecast, By Product Type (2016-2030)

9.3.5.    Japan

9.3.5.1.        Market Revenue and Forecast, By Treatment Type (2016-2030)

9.3.5.2.        Market Revenue and Forecast, By Product Type (2016-2030)

9.3.6.    Rest of APAC

9.3.6.1.        Market Revenue and Forecast, By Treatment Type (2016-2030)

9.3.6.2.        Market Revenue and Forecast, By Product Type (2016-2030)

9.4.  MEA

9.4.1.    Market Revenue and Forecast, By Treatment Type (2016-2030)

9.4.2.    Market Revenue and Forecast, By Product Type (2016-2030)

9.4.3.    GCC

9.4.3.1.        Market Revenue and Forecast, By Treatment Type (2016-2030)

9.4.3.2.        Market Revenue and Forecast, By Product Type (2016-2030)

9.4.4.    North Africa

9.4.4.1.        Market Revenue and Forecast, By Treatment Type (2016-2030)

9.4.4.2.        Market Revenue and Forecast, By Product Type (2016-2030)

9.4.5.    South Africa

9.4.5.1.        Market Revenue and Forecast, By Treatment Type (2016-2030)

9.4.5.2.        Market Revenue and Forecast, By Product Type (2016-2030)

9.4.6.    Rest of MEA

9.4.6.1.        Market Revenue and Forecast, By Treatment Type (2016-2030)

9.4.6.2.        Market Revenue and Forecast, By Product Type (2016-2030)

9.5.  Latin America

9.5.1.    Market Revenue and Forecast, By Treatment Type (2016-2030)

9.5.2.    Market Revenue and Forecast, By Product Type (2016-2030)

9.5.3.    Brazil

9.5.3.1.        Market Revenue and Forecast, By Treatment Type (2016-2030)

9.5.3.2.        Market Revenue and Forecast, By Product Type (2016-2030)

9.5.4.    Rest of LATAM

9.5.4.1.        Market Revenue and Forecast, By Treatment Type (2016-2030)

9.5.4.2.        Market Revenue and Forecast, By Product Type (2016-2030)

Chapter 10.  Company Profiles

10.1.              Vuvatech

10.1.1.  Company Overview

10.1.2.  Product Offerings

10.1.3.  Financial Performance

10.1.4.  Recent Initiatives

10.2.              Owen Mumford Ltd.

10.2.1.  Company Overview

10.2.2.  Product Offerings

10.2.3.  Financial Performance

10.2.4.  Recent Initiatives

10.3.              KESSEL medintim GmbH

10.3.1.  Company Overview

10.3.2.  Product Offerings

10.3.3.  Financial Performance

10.3.4.  Recent Initiatives

10.4.              Phuket Plastic Surgery Institute (PPSI)

10.4.1.  Company Overview

10.4.2.  Product Offerings

10.4.3.  Financial Performance

10.4.4.  Recent Initiatives

10.5.              Chettawut Plastic Surgery Center

10.5.1.  Company Overview

10.5.2.  Product Offerings

10.5.3.  Financial Performance

10.5.4.  Recent Initiatives

10.6.              González-Fontana

10.6.1.  Company Overview

10.6.2.  Product Offerings

10.6.3.  Financial Performance

10.6.4.  Recent Initiatives

10.7.              Icahn School of Medicine at Mount Sinai

10.7.1.  Company Overview

10.7.2.  Product Offerings

10.7.3.  Financial Performance

10.7.4.  Recent Initiatives

Chapter 11.  Research Methodology

11.1.              Primary Research

11.2.              Secondary Research

11.3.              Assumptions

Chapter 12.  Appendix

12.1.              About Us

12.2.              Glossary of Terms

Report Details

  • Report Code:37229
  • Category:Healthcare
  • No. of Pages:250
  • Format:PDF/PPT/Excel
  • Published:February 2021
  • Historical Year:2021-2022
  • Base Year:2023
  • Estimated Year:2024-2033

Proceed To Buy

USD 4500
USD 3800
USD 1900
USD 1200

Customization Offered

  • check-imgCross-segment Market Size and Analysis for Mentioned Segments
  • check-imgAdditional Company Profiles (Upto 5 With No Cost)
  • check-img Additional Countries (Apart From Mentioned Countries)
  • check-img Country/Region-specific Report
  • check-img Go To Market Strategy
  • check-imgRegion Specific Market Dynamics
  • check-imgRegion Level Market Share
  • check-img Import Export Analysis
  • check-imgProduction Analysis
  • check-imgOthers